Michael P Curry

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint HIV and hepatitis C virus: special concerns for patients with cirrhosis
    Michael P Curry
    Liver Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    J Infect Dis 207:S40-4. 2013
  2. ncbi request reprint Hepatitis B and hepatitis C viruses in liver transplantation
    Michael P Curry
    Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Transplantation 78:955-63. 2004
  3. ncbi request reprint The gallbladder and biliary tract in cystic fibrosis
    Michael P Curry
    Liver Transplantation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Curr Gastroenterol Rep 7:147-53. 2005
  4. ncbi request reprint Use of growth factors with antiviral therapy for chronic hepatitis C
    Michael P Curry
    Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
    Clin Liver Dis 9:439-51, vii. 2005
  5. doi request reprint Timing of sirolimus conversion influences recovery of renal function in liver transplant recipients
    Christin C Rogers
    Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, USA
    Clin Transplant 23:887-96. 2009
  6. doi request reprint Liver transplant center risk tolerance
    Scott R Johnson
    The Transplant Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Clin Transplant 26:E269-76. 2012
  7. doi request reprint Peripheral platelet count correlates with liver atrophy and predicts long-term mortality on the liver transplant waiting list
    Wissam Bleibel
    Liver Center, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA, USA
    Transpl Int 26:435-42. 2013
  8. doi request reprint A Simultaneous Liver-Kidney Transplant Recipient With IgA Nephropathy Limited to Native Kidneys and BK Virus Nephropathy Limited to the Transplant Kidney
    Manasa P Ujire
    The Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA
    Am J Kidney Dis 62:331-4. 2013
  9. doi request reprint Patients' expectations and success criteria for liver transplantation
    James R Rodrigue
    Center for Transplant Outcomes and Quality Improvement, Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA
    Liver Transpl 17:1309-17. 2011
  10. doi request reprint Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation
    Karen J Ho
    Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Transplantation 85:1588-94. 2008

Collaborators

Detail Information

Publications13

  1. doi request reprint HIV and hepatitis C virus: special concerns for patients with cirrhosis
    Michael P Curry
    Liver Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    J Infect Dis 207:S40-4. 2013
    ....
  2. ncbi request reprint Hepatitis B and hepatitis C viruses in liver transplantation
    Michael P Curry
    Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Transplantation 78:955-63. 2004
    ..This review summarizes available data and highlights appropriate strategies to improve outcomes...
  3. ncbi request reprint The gallbladder and biliary tract in cystic fibrosis
    Michael P Curry
    Liver Transplantation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Curr Gastroenterol Rep 7:147-53. 2005
    ..Liver transplantation can be performed successfully in patients with end-stage liver disease. Future treatments involve targeted gene therapy and activation of mutant forms of the cystic fibrosis transmembrane conductance regulator...
  4. ncbi request reprint Use of growth factors with antiviral therapy for chronic hepatitis C
    Michael P Curry
    Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
    Clin Liver Dis 9:439-51, vii. 2005
    ....
  5. doi request reprint Timing of sirolimus conversion influences recovery of renal function in liver transplant recipients
    Christin C Rogers
    Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, USA
    Clin Transplant 23:887-96. 2009
    ..The only improvement in the LC group was from conversion to the three-month time point. We conclude that EC to SRL results in a profound improvement in eGFR that begins at three months and is sustained beyond one yr...
  6. doi request reprint Liver transplant center risk tolerance
    Scott R Johnson
    The Transplant Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Clin Transplant 26:E269-76. 2012
    ..Small volume centers must perform higher risk transplants to meet current CMS requirements and are at risk for adverse action secondary to chance alone...
  7. doi request reprint Peripheral platelet count correlates with liver atrophy and predicts long-term mortality on the liver transplant waiting list
    Wissam Bleibel
    Liver Center, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA, USA
    Transpl Int 26:435-42. 2013
    ..01), but no different transplantation rate (36.7% vs. 33.3%, P = 0.64) compared to those with platelet count ≥ 100,000/mcL. Low platelet count corresponds to higher waiting list mortality and is a sign of advanced liver atrophy...
  8. doi request reprint A Simultaneous Liver-Kidney Transplant Recipient With IgA Nephropathy Limited to Native Kidneys and BK Virus Nephropathy Limited to the Transplant Kidney
    Manasa P Ujire
    The Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA
    Am J Kidney Dis 62:331-4. 2013
    ..These findings confirm the predilection of BK virus nephropathy for transplant rather than native kidneys. ..
  9. doi request reprint Patients' expectations and success criteria for liver transplantation
    James R Rodrigue
    Center for Transplant Outcomes and Quality Improvement, Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA
    Liver Transpl 17:1309-17. 2011
    ..Patient-centered assessments have the potential to facilitate provider-patient communication by helping patients to prioritize their goals for LT and make informed choices on the basis of those priorities...
  10. doi request reprint Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation
    Karen J Ho
    Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Transplantation 85:1588-94. 2008
    ..We hypothesized that donor postextubation parameters, including duration and severity of hemodynamic instability or hypoxia might be a better predictor of subsequent graft function...
  11. ncbi request reprint Atypical radiological presentation of progressive multifocal leukoencephalopathy following liver transplantation
    Marco A Lima
    Department of Neurology, Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    J Neurovirol 11:46-50. 2005
    ..The authors report an atypical presentation of PML with contrast-enhancing lesions and mass effect on the MRI in a liver transplant recipient,who had a progressive course and fatal outcome...
  12. ncbi request reprint Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver
    Michael P Curry
    The Liver Unit, St Vincent s University Hospital, Elm Park, Dublin 4, Ireland
    J Hepatol 38:642-50. 2003
    ....
  13. ncbi request reprint Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection
    Tina Deignan
    Education and Research Centre, St Vincent s University Hospital, Elm Park, Dublin 4, Ireland
    J Hepatol 37:101-8. 2002
    ..It is not known which of these populations contribute to immunity against HCV or immune pathology...